GENTA INCORPORATED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

  • No Technology to Display

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

  • No Recent Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
7855183 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomersExpiredDec 16, 03Dec 21, 10[A61K, C07H, A01N]
7795232 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomersExpiredNov 10, 00Sep 14, 10[A61K, C07H, A01N]
2010/0216,867 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomersAbandonedApr 02, 10Aug 26, 10[A61K, A61P]
2009/0275,654 Pharmaceutical Gallium Compositions and MethodsAbandonedApr 28, 09Nov 05, 09[A61K, C07F, A61P]
2009/0275,655 Pharmaceutical Gallium Compositions and MethodsAbandonedApr 28, 09Nov 05, 09[A61K]
2008/0171,718 Methods and Compositions for Treating Cancer Using BCL-2 Antisense Oligomers, Tyrosine Kinase Inhibitors, and Chemotherapeutic AgentsAbandonedNov 06, 07Jul 17, 08[A61K, C12N, A61P]
2007/0270,371 Dosing and scheduling of oligomersAbandonedMar 30, 07Nov 22, 07[A61K, A61P]
7256284 Inhibitory oligonucleotides targeted to Bcl-2ExpiredNov 14, 03Aug 14, 07[C07H]
2006/0275,308 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasiaAbandonedAug 07, 06Dec 07, 06[A61K]
7119217 Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing themExpiredSep 22, 03Oct 10, 06[C07F]
7060690 Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereofExpiredJan 22, 02Jun 13, 06[C07H]
2004/0191,328 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasiaAbandonedDec 31, 03Sep 30, 04[A61K]
2004/0147,473 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomersAbandonedDec 16, 03Jul 29, 04[A61K]
6638529 Amide-based cationic lipidsExpiredJan 14, 02Oct 28, 03[A61K, L07G]
6562870 Treatment of AIDS-associated non-Hodgkin's lymphoma by gallium nitrateExpiredSep 14, 95May 13, 03[A61K]
6262036 Method for inhibiting RNA translation using chimeric oligonucleoside compoundsExpiredJan 24, 00Jul 17, 01[C07H, A01N]
6060456 Chimeric oligonucleoside compoundsExpiredOct 27, 97May 09, 00[C07H, C12Q, A01N]
6028188 Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkagesExpiredNov 21, 94Feb 22, 00[C07H]
6005094 Oligonucleotide analogues having improved stability at acid pHExpiredDec 27, 94Dec 21, 99[C07H]
5986083 Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkagesExpiredNov 17, 94Nov 16, 99[C07H]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.